Stock SE SWEET EARTH HOLDINGS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sweet Earth Holdings Corporation

Equities

SE

CA87039X3076

Pharmaceuticals

Market Closed - Canadian Securities Exchange
Other stock markets
 01:23:52 2024-04-23 pm EDT 		5-day change 1st Jan Change
0.05 CAD -9.09% Intraday chart for Sweet Earth Holdings Corporation -9.09% +66.67%
Feb. 28 Sweet Earth Holdings Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Feb. 23 Sweet Earth Holdings Corporation announced that it expects to receive CAD 0.0875 million in funding CI

Valuation

Fiscal Period: June 2020 2021 2022 2023
Capitalization 1 18.27 15.48 1.906 2.177
Enterprise Value (EV) 1 20.1 16.6 2.884 2.051
P/E ratio -4.47 x -3.15 x -0.59 x -4.75 x
Yield - - - -
Capitalization / Revenue - 77,141,527 x 21,630,691 x 51,509,964 x
EV / Revenue - 82,702,259 x 32,731,286 x 48,549,108 x
EV / EBITDA -10.4 x -3.52 x -2.39 x -4.17 x
EV / FCF -8,195,935 x -9,317,332 x -6,267,180 x -4,003,978 x
FCF Yield -0% -0% -0% -0%
Price to Book 6.5 x 17.6 x -2.27 x -4.6 x
Nbr of stocks (in thousands) 1,986 2,497 2,803 12,803
Reference price 2 9.200 6.200 0.6800 0.1700
Announcement Date 10/28/20 10/28/21 10/28/22 11/22/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023
Net sales - - 0.2007 0.0881 0.0423
EBITDA 1 -2.128 -1.937 -4.712 -1.205 -0.4922
EBIT 1 -2.133 -2.048 -4.83 -1.298 -0.4991
Operating Margin - - -2,406.12% -1,473.21% -1,181.28%
Earnings before Tax (EBT) 1 -2.198 -3.34 -4.918 -3.147 -0.1179
Net income 1 -2.198 -3.34 -4.918 -3.147 -0.1179
Net margin - - -2,450% -3,571.29% -278.95%
EPS 2 -8.274 -2.056 -1.967 -1.159 -0.0358
Free Cash Flow - -2.452 -1.782 -0.4602 -0.5123
FCF margin - - -887.62% -522.26% -1,212.52%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 5/25/20 10/28/20 10/28/21 10/28/22 11/22/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023
Net Debt 1 0.57 1.83 1.12 0.98 -
Net Cash position 1 - - - - 0.13
Leverage (Debt/EBITDA) -0.2674 x -0.9425 x -0.2369 x -0.8116 x -
Free Cash Flow - -2.45 -1.78 -0.46 -0.51
ROE (net income / shareholders' equity) - -158% -450% -15,493% 17.9%
ROA (Net income/ Total Assets) - -28.3% -76% -36.3% -43%
Assets 1 - 11.82 6.472 8.665 0.2741
Book Value Per Share 2 0.9700 1.420 0.3500 -0.3000 -0.0400
Cash Flow per Share 2 0.2500 0.0100 0.0300 0.0500 0.0100
Capex 1 0.69 0.85 - 0.02 -
Capex / Sales - - - 21.74% -
Announcement Date 5/25/20 10/28/20 10/28/21 10/28/22 11/22/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Alternative Medicine

1st Jan change Capi.
SWEET EARTH HOLDINGS CORPORATION Stock Sweet Earth Holdings Corporation
+66.67% 468K
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+35.04% 5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.13% 4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.75% 3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+2.14% 3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-6.82% 2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+47.87% 1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-7.89% 1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+0.09% 1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.97% 1.53B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. SE Stock
  4. Financials Sweet Earth Holdings Corporation